News
4h
Health on MSNThis New Pill Could Rival Ozempic and Wegovy—Will It Make Weight Loss Drugs More Accessible?Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
8h
YourErie on MSNAre weight loss drugs safe? Learn some of the side effectsWeight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...
As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the drugs for people with eating disorders.
Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...
A GRAN who shed more than five stone on Mounjaro is now fundraising to have surgery abroad – as she compares her saggy skin ...
IT feels like everyone is talking about – or taking – weight loss medications like Wegovy or Mounjaro. The jabs have ...
Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...
I never imagined that coming off a medication could feel like stepping off a cliff. But here I am, bracing for the freefall.
Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...
Shivaji Dasgupta, an autonomous Brand Consultant, writes that India’s obsession with shortcuts risks turning a breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results